The Law Offices of Wallace & Graham
Helping Asbestos & Mesothelioma Victims Nationwide Call for a Free Consultation
888.698.9975

August 2017 Archives

Securing compensation for foreign claimants

North Carolinian military members may serve abroad, and American employers may have employees working in other countries. But, American-made products are found throughout the world. As such, asbestos exposure does not need to happen in the U.S. for an American citizen to pursue asbestos litigation. In addition, foreign claimants have standing -- just like U.S. citizens -- to bring civil lawsuits in U.S. courts.

Early signs of lung disease linked to workplace exposure

A recent study conducted by the Interstitial Lung Disease (ILD) Program at Columbia University Medical Center revealed a link between early signs of lung disease and workplace exposures to vapors, gas, dust and fumes. Interstitial lung disease is a medical term used to describe over 100 types of diseases, characterized by fibrosis in the alveoli of the lungs. ILDs include black lung -- caused by the inhalation of coal mine dust, asbestosis -- an often-fatal asbestos disease affecting the lungs and pulmonary sarcoidosis -- an inflammatory disease often attributed to toxic exposure.

The benefits of asbestos trust disclosure reforms

In the past few years, there has been a detrimental trend in North Carolina asbestos litigation, according to the director of the Progressive Policy Institute's Center for Civil Justice (CCJ). The trend involves plaintiffs' lawyers hiding pertinent facts. The CCJ director suggests that the implementation of transparency laws, such as the ones recently introduced in 12 other states, would be beneficial for current and future plaintiffs.

$480 million North Carolina asbestos trust fund case

Recently, a North Carolina federal judge decided whether Safety National Casualty, Corp., must pay $480 million to the mesothelioma fund. The fund was established in the Chapter 11 bankruptcy plan for Garlock Sealing Technologies, Inc., after Garlock declared bankruptcy in 2010, following years of asbestos litigation. Safety National claims that Garlock is not covered under the $5 million excess policy that Safety National issued to Garlock over 30-years ago.

Clinical trial for pleural mesothelioma drug ends

Mesothelioma patients may be disappointed to learn that a trial of a new mesothelioma drug, anetumab ravtansine, was stopped after the drug was proven to be less effective than an existing drug, vinorelbine. The results of Bayer's Phase II clinical trial showed that the new drug designed to treat recurrent malignant mesothelioma did not slow progression of mesothelioma better than vinorelbine and therefore the trial did not meet its primary endpoint.

525 North Main Street
Salisbury, NC 28144

Toll Free: 888-698-9975
Phone: 704-754-8242
Map & Directions